Skip to main content


  • AddRemove
  • Build a Report 
Media Coverage

Generic-Drug Users Can't Pin Brand-Name Cos., NJ Court Says

28 June 2012
A New Jersey judge dismissed allegations Tuesday from users of generic versions of the heartburn medication Reglan that the drug's brand-name manufacturers, including Wyeth LLC, misrepresented its risks, finding the U.S. Supreme Court's Mensing decision did not address brand-name companies' duty to generics users.

Related Information

  • Related People
    Andrew J. Calica
    T +1 212 506 2256
    Henninger S. Bullock
    T +1 212 506 2528

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.